What is the Digital Pathology Market Size?
The global digital pathology market size was valued at USD 1.28 billion in 2025 and is projected to grow from USD 1.39 billion in 2026 to approximately USD 2.76 billion by 2035, registering a CAGR of 7.99% from 2026 to 2035. The increasing prevalence of chronic disorders is a major factor driving market growth. North America accounted for a significant share of the market, with the regional market size reaching USD 490 million in 2025.
Get Sample : https://www.precedenceresearch.com/sample/4738
Digital Pathology Market Key Takeaways
- The global digital pathology market was valued at USD 1.28 billion in 2025.
- It is projected to reach USD 2.76 billion by 2035.
- The digital pathology market is expected to grow at a CAGR of 7.99% from 2026 to 2035.
- North America dominated the digital pathology market with the largest market share of 41% in 2025.
- Asia Pacific is estimated to be the fastest-growing during the forecast period of 2026 to 2035.
- By product, the device segment has contributed more than 53% of market share in 2025.
- By product, the software segment is expected to be the fastest-growing during the forecast period.
- By type, the human pathology segment has held a major market share of 61% in 2025.
- By type, the veterinary pathology segment is anticipated to be the fastest-growing during the forecast period.
- By application, the academic research segment accounted for the largest market share of 47% in 2025.
- By application, the disease diagnosis segment is estimated to be the fastest-growing during the forecast period.
- By end-use, the hospitals segment has generated more than 38% of market share in 2025.
- By end-use, the diagnostic labs segment is anticipated to be the fastest-growing during the forecast period.
What is Digital Pathology?
The digital pathology market involves the conversion of glass slides containing tissue samples into high-resolution digital images for analysis, storage, and sharing. It is a specialized branch of pathology focused on managing and interpreting information generated from digitized specimen slides. By integrating computer-based technologies, digital pathology enables the use of virtual microscopy for efficient diagnostic evaluation.
Digital pathology offers several advantages, including AI-based disease screening, reduced workload and fatigue for pathologists, faster and more accurate diagnostic results, and improved patient outcomes. It also supports standardization in pathology education and ensures transparent and consistent evaluations. In addition, teleconsultation capabilities allow pathologists to collaborate, review, and assess cases remotely in real time, further contributing to the growth of the digital pathology market.
How is AI contributing to the Digital Pathology Industry?
Artificial intelligence is transforming digital pathology by automating slide analysis and supporting pathologists in complex diagnostic assessments. AI-powered systems utilize digital images to detect tumors, measure biomarkers, and classify tissue patterns using advanced machine learning algorithms. These technologies can highlight suspicious regions for further review, improving diagnostic accuracy, enhancing workflow efficiency, and reducing the time required for pathology evaluations.
Digital Pathology Market Scope
| Report Coverage | Details |
| Market Size by 2035 | USD 2.76 Billion |
| Market Size in 2025 | USD 1.28 Billion |
| Market Size in 2026 | USD 1.39 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 7.99% |
| Largest Market | North America |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
Regional Insights
What is the U.S. Digital Pathology Market Size?
The U.S. digital pathology market size was exhibited at USD 390 million in 2025 and is projected to be worth around USD 870 million by 2035, poised to grow at a CAGR of 8.35% from 2026 to 2035.
North America dominated the digital pathology market in 2025. Rising government initiatives for the development of advanced pathology technologies, increasing adoption of digital imaging, and R&D investments help the growth of the market in the North American region.
U.S. Digital Pathology Market Trends
The market of digital pathology in the U.S. grows with the high level of integration of artificial intelligence into the diagnostic processes. The adoption of artificial intelligence-based pathology software is promoted by regulatory clearances. Telepathology systems that provide remote consultation, collaboration, and workload management are increasingly being used by healthcare providers to operate across hospital networks and specialized oncology laboratories.
Asia Pacific is estimated to be the fastest-growing during the forecast period of 2026 to 2035. Increasing digital imaging penetration, increasing investment, and rapid digitalization in the medical field can help the growth of the digital pathology market in the Asia Pacific region.
Digital Pathology Market Companies
- Bionovation Biotech Inc.: Innovates ultra-fast whole slide scanners with high resolution imaging, remote consultation solutions, and adjustable artificial intelligence training solutions.
- Morphle Labs Inc.: Offers robotic microscopes and cloud software, which is intended to serve automated cancer diagnostics, high throughput scanning, and distant pathology association.
- SigTuple Technologies Private Limited: Presents AI-enabled robotic microscopy systems that digitize blood and urine smears and allow automated laboratory examination and better diagnosis.
Other Major Key Players
- IBEX (IBEX MEDICAL ANALYTICS)
- aetherAI
- West Medica Produktions- und Handles- GmbH (West Medica)
- HANGZHOU ZHIVEI INFORMATION TECHNOLOGY CO.LTD. (MORPHOGO)
- CellaVision
- ContextVision AB
- Huron Technologies International Inc.
- Visiopharm A/S
- Epredia (3DISTECH Ltd.)
- Inspirata, Inc.
- Mikroscan Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- Olympus Corporation
- Koninklijke Philips N.V.
- Hamamatsu Photonics, Inc.
- Leica Biosystems Nussloch GmbH (Danaher)
Recent Developments
- In March 2026, Philips introduced the IntelliSite Pathology Solution on HealthSuite, a cloud-based platform using AWS. It facilitates secure storage and analysis of high-resolution pathology images, enabling remote collaboration for pathologists. The solution aims to enhance workflow efficiency and promote digital pathology’s clinical use. (https://clpmag.com/diagnostic-technologies )
- In December 2026, Leica Biosystems, a Danaher company, announces the launch of the Aperio GT 180 DX scanner, Aperio CS5 DX scanner, and Aperio iQC DX software, advancing digital pathology. These innovations debuted at the Digital Pathology and AI Congress in London, enhancing the Aperio Digital Pathology clinical portfolio showcased at booth . (https://www.prnewswire.com )
- In November 2023, PharmaNest Inc., Alimentiv Inc., and AcelaBio Inc. collaborated to revolutionize precision medicine and AI-based digital pathology for MASH (metabolic dysfunction associated steatohepatitis)/NASH (nonalcoholic steatohepatitis) clinical trials.
- In April 2024, Sectra and Leica Biosystems, Imaging Inc. received clearance from the Food and Drug Administration (FDA) for the use of DICOM images in digital pathology for pathology diagnostics.
- In July 2024, Philips IntelliSite Pathology Solution received 510 (K) clearance to strengthen Philips’s leadership in digital pathology. This helps to improve diagnostics efficiency and accuracy by integrating pathology into broader IT infrastructure and precision diagnostics systems.
Segments Covered in the Report
By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
By Type
- Human Pathology
- Veterinary Pathology
By Application
- Drug Discovery and Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344